Engaging the Community in Designing a Hepatitis C Virus Treatment Program for Adults Experiencing Homelessness.

Hepatitis C Virus designing an HCV treatment program in Los Angeles for homeless adults homeless adults qualitative community-based participatory design

Journal

Qualitative health research
ISSN: 1049-7323
Titre abrégé: Qual Health Res
Pays: United States
ID NLM: 9202144

Informations de publication

Date de publication:
09 2021
Historique:
pubmed: 1 7 2021
medline: 30 11 2021
entrez: 30 6 2021
Statut: ppublish

Résumé

Despite the availability of cure for hepatitis C virus (HCV), people experiencing homelessness (PEH) are challenged with initiating and completing HCV treatment. The design of culturally sensitive HCV treatment programs is lacking. The objective was to employ community-based participatory research methods to understand perceptions of HCV-positive PEH, and providers, on the design and delivery of a culturally sensitive, nurse-led community health worker (RN/CHW) HCV initiation and completion program. Four focus group sessions were conducted with HCV-positive PEH (

Identifiants

pubmed: 34189974
doi: 10.1177/10497323211021782
pmc: PMC10593144
mid: NIHMS1933849
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Pagination

2069-2083

Subventions

Organisme : NIMHD NIH HHS
ID : R21 MD013580
Pays : United States

Références

Dig Dis Sci. 2020 Oct;65(10):3023-3031
pubmed: 31974916
Qual Health Res. 2018 Nov;28(13):2011-2019
pubmed: 29972082
Int J Environ Res Public Health. 2020 Nov 11;17(22):
pubmed: 33187301
Nurs Res. 2015 May-Jun;64(3):177-89
pubmed: 25932697
Hepatol Commun. 2020 Mar 03;4(5):646-656
pubmed: 32363316
BMC Infect Dis. 2020 May 29;20(1):386
pubmed: 32471376
BMJ Open. 2018 Apr 7;8(4):e020161
pubmed: 29627814
Lancet Infect Dis. 2012 Nov;12(11):859-70
pubmed: 22914343
Lancet. 2015 Mar 21;385(9973):1107-13
pubmed: 25591505
Intern Med J. 2019 Apr;49(4):455-460
pubmed: 30324639
Harm Reduct J. 2017 Nov 28;14(1):76
pubmed: 29179765
Int J Offender Ther Comp Criminol. 2018 Nov;62(15):4796-4813
pubmed: 30058395
BMC Infect Dis. 2019 Feb 7;19(1):128
pubmed: 30732573
Drug Alcohol Depend. 2018 Sep 1;190:246-254
pubmed: 30071457
J Viral Hepat. 2020 Feb;27(2):176-187
pubmed: 31566851
Qual Health Res. 2020 Jan;30(2):182-195
pubmed: 31274048
Int J Infect Dis. 2020 Feb;91:246-251
pubmed: 31785401
Qual Health Res. 2019 Nov;29(13):1839-1849
pubmed: 30810072
Public Health Rep. 2003 Jul-Aug;118(4):293-302
pubmed: 12815076
Clin Infect Dis. 2013 Aug;57 Suppl 2:S51-5
pubmed: 23884066
AIDS Behav. 2019 Sep;23(9):2443-2452
pubmed: 31098747
J Antimicrob Chemother. 2019 Nov 1;74(Suppl 5):v17-v23
pubmed: 31782500
Int J Drug Policy. 2019 Oct;72:99-105
pubmed: 31303262
J Int AIDS Soc. 2017 Jul 28;20(1):22146
pubmed: 28782335
J Community Health. 2019 Dec;44(6):1044-1054
pubmed: 31127412
AIDS Patient Care STDS. 2010 Dec;24(12):753-62
pubmed: 21138381
Ann Hepatol. 2019 Mar - Apr;18(2):304-309
pubmed: 31053544
Nurs Res. 2017 Nov/Dec;66(6):432-441
pubmed: 29095374
Public Health. 2018 Jan;154:151-160
pubmed: 29245022
ScientificWorldJournal. 2012;2012:580216
pubmed: 23346018
Public Health Rep. 2012 Jul-Aug;127(4):407-21
pubmed: 22753984
BMJ Open Gastroenterol. 2017 Dec 20;4(1):e000181
pubmed: 29333275
Int J Environ Res Public Health. 2016 Sep 24;13(10):
pubmed: 27669284
Hepatology. 2019 Mar;69(3):1020-1031
pubmed: 30398671
Health Soc Care Community. 2020 Mar;28(2):414-422
pubmed: 31577380
BMC Public Health. 2017 Feb 7;17(1):171
pubmed: 28173785
Int J Qual Health Care. 2007 Dec;19(6):349-57
pubmed: 17872937
Community Ment Health J. 2017 Aug;53(6):688-694
pubmed: 28540538
Health (Irvine Calif). 2016 Sep;8(12):1143-1165
pubmed: 28042394
Int J Drug Policy. 2019 Oct;72:138-145
pubmed: 30995968
JAMA Netw Open. 2020 Sep 1;3(9):e2015756
pubmed: 32880650
Clin Infect Dis. 2019 Nov 27;69(12):2218-2227
pubmed: 31352481
Clin Gastroenterol Hepatol. 2015 Nov;13(11):2005-14.e1-3
pubmed: 25724704
ANS Adv Nurs Sci. 2017 Jul/Sep;40(3):278-288
pubmed: 27930402
Harm Reduct J. 2016 Sep 15;13(1):25
pubmed: 27629248
Liver Int. 2020 May;40(5):1021-1031
pubmed: 32048798
Int J Drug Policy. 2019 Oct;72:195-198
pubmed: 30981613
Qual Health Res. 2004 Apr;14(4):513-25
pubmed: 15068577
J Health Commun. 2018;23(1):117-127
pubmed: 29252118
Community Ment Health J. 2021 May;57(4):609-621
pubmed: 33387178
Harm Reduct J. 2019 Feb 11;16(1):14
pubmed: 30744628
Psychiatr Serv. 2006 Apr;57(4):570-2
pubmed: 16603757

Auteurs

Adeline M Nyamathi (AM)

University of California, Irvine, Irvine, California, USA.

Sarah Akure Wall (SA)

University of California, Los Angeles, Los Angeles, California, USA.

Kartik Yadav (K)

University of California, Irvine, Irvine, California, USA.

Sanghyuk S Shin (SS)

University of California, Irvine, Irvine, California, USA.

Alicia Chang (A)

Los Angeles County Department of Public Health, Los Angeles, California, USA.

Nicholas Arce (N)

University of California, Irvine, Irvine, California, USA.

Helena Cuellar (H)

University of California, Irvine, Irvine, California, USA.

Shannon Fernando (S)

Los Angeles Christian Health Centers, Los Angeles, California, USA.

Kathryn White (K)

Los Angeles Christian Health Centers, Los Angeles, California, USA.

Lillian Gelberg (L)

David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
VA Greater Los Angeles Healthcare System, Los Angeles, California, USA.

Benissa E Salem (BE)

University of California, Los Angeles, Los Angeles, California, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH